BaTelab Co Ltd logo

BaTelab Co Ltd

2149.HK

HKSETechnologySemiconductors

Latest quote

HK$33.02

−HK$1.78 · -5.11%

Aug 24, 4:08 PM HKT

2149.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

BaTeLab Co., Ltd. focuses on the research, development, and commercialization of analog integrated circuit (IC) patterned wafers, which are crucial for packaging and testing solutions across China. The company boasts a comprehensive catalog of power management products, including AC-DC and DC-DC switching regulators, multi-channel ICs, power management integrated circuits (PMICs), linear regulators, battery management ICs, and various monitoring, modulating, and driver ICs. Additionally, BaTeLab supplies signal chain offerings, such as linear products. These advanced components find wide application in diverse sectors like automotive electronics, healthcare, industrial automation, the Industrial Internet of Things (IIoT), industrial lighting, instrumentation, communications, electric power, energy storage, and consumer electronics. Founded in 2010, BaTeLab Co., Ltd. maintains its corporate headquarters in Suzhou, China.

Industry
Semiconductors
Sector
Technology
Headquarters
CN
CEO
Guangping Zhang
Listed since
Dec 28, 2023
Employees
111

Market position

Day range

Current HK$33.02

52-week range

Current HK$33.02

Open
HK$34.80
Previous close
HK$34.80
Volume
45K
0.49× average
Average volume
92.45K
Average daily volume
Market cap
2.04B HKD
Beta
1.26
Market reference 1
50-day average
HK$31.6164
+4.44% above average
200-day average
HK$38.3939
-14.00% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.22B CNY
P/E (TTM)
14.38×
P/B (TTM)
1.41×
P/S (TTM)
3.02×
EV / EBITDA
17.91×
Earnings yield
4.98%
Free cash flow yield
-4.64%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
51.57%
Operating margin
21.50%
Net margin
20.93%
Return on equity
9.26%
Return on assets
6.45%
Return on invested capital
7.44%

Financial health

Debt / equity
0.34×
Current ratio
2.87×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends73%54%35%16%Gross margin, FY2021: 67.99%Gross margin, FY2022: 56.54%Gross margin, FY2023: 55.43%Gross margin, FY2024: 53.03%Gross margin, FY2025: 51.74%Operating margin, FY2021: 28.61%Operating margin, FY2022: 24.02%Operating margin, FY2023: 24.45%Operating margin, FY2024: 30.05%Operating margin, FY2025: 21.94%Net margin, FY2021: 26.78%Net margin, FY2022: 23.24%Net margin, FY2023: 23.53%Net margin, FY2024: 28.78%Net margin, FY2025: 20.35%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 67.99%. Gross margin FY2022 56.54%. Gross margin FY2023 55.43%. Gross margin FY2024 53.03%. Gross margin FY2025 51.74%. Operating margin FY2021 28.61%. Operating margin FY2022 24.02%. Operating margin FY2023 24.45%. Operating margin FY2024 30.05%. Operating margin FY2025 21.94%. Net margin FY2021 26.78%. Net margin FY2022 23.24%. Net margin FY2023 23.53%. Net margin FY2024 28.78%. Net margin FY2025 20.35%.

Income trends

Revenue

584.12M CNY+0.92%

Operating income

128.14M CNY-26.33%

Net income

118.85M CNY-28.66%
Income trends across reported periods636.84M CNY425.98M CNY215.12M CNY4.25M CNYRevenue, FY2021: 212.71M CNYRevenue, FY2022: 409.93M CNYRevenue, FY2023: 463.88M CNYRevenue, FY2024: 578.81M CNYRevenue, FY2025: 584.12M CNYOperating income, FY2021: 60.85M CNYOperating income, FY2022: 98.48M CNYOperating income, FY2023: 113.43M CNYOperating income, FY2024: 173.95M CNYOperating income, FY2025: 128.14M CNYNet income, FY2021: 56.97M CNYNet income, FY2022: 95.26M CNYNet income, FY2023: 109.16M CNYNet income, FY2024: 166.6M CNYNet income, FY2025: 118.85M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 212.71M CNY. Revenue FY2022 409.93M CNY. Revenue FY2023 463.88M CNY. Revenue FY2024 578.81M CNY. Revenue FY2025 584.12M CNY. Operating income FY2021 60.85M CNY. Operating income FY2022 98.48M CNY. Operating income FY2023 113.43M CNY. Operating income FY2024 173.95M CNY. Operating income FY2025 128.14M CNY. Net income FY2021 56.97M CNY. Net income FY2022 95.26M CNY. Net income FY2023 109.16M CNY. Net income FY2024 166.6M CNY. Net income FY2025 118.85M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue584.12M CNY578.81M CNY463.88M CNY409.93M CNY212.71M CNY
Cost of goods sold281.87M CNY271.89M CNY206.77M CNY178.14M CNY111.74M CNY
Gross profit302.25M CNY306.92M CNY257.11M CNY231.79M CNY144.63M CNY
Research and development141.38M CNY129.22M CNY119.15M CNY84.88M CNY47.61M CNY
Selling, general, and administrative36.42M CNY38.59M CNY32.63M CNY25.76M CNY4.75M CNY
Operating expenses174.11M CNY132.97M CNY143.68M CNY100.85M CNY59.15M CNY
Interest income14.09M CNY14.03M CNY1.75M CNY495K CNY166K CNY
Interest expense8.77M CNY7.99M CNY4.27M CNY1.65M CNY3.88M CNY
Depreciation and amortization8.82M CNY5.06M CNY5.59M CNY1.15M CNY684K CNY
Operating income128.14M CNY173.95M CNY113.43M CNY98.48M CNY60.85M CNY
Net income118.85M CNY166.6M CNY109.16M CNY95.26M CNY56.97M CNY

Company facts updated Aug 24, 2026.

2149.HK peers

ETFs holding 2149.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 2149.HK

research.disclaimer